Where Will CRISPR Therapeutics Be in 3 Years? [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
Now, its challenge is to build on its prior successes to become a biotech powerhouse and prove to investors that it isn't a one-trick pony. The next three years will be critical for both of those things. Here's what to expect. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free » By late 2027, CRISPR will be a larger biotech, with much more revenue, more collaborators, and a much bigger pipeline -- but still probably not any profits. Management's plan for the long term is to initiate one or two investigational new drug programs per year. That means it aims to start that many phase 1 trials of candidates that aren't already in its clinical-stage pipeline. In other words, the goal is not just to expand the set of approved indications for its existing therapies, but rather to pioneer wholly new treatments, likely for different diseases or targets each time. Pursuing such a strategy is ambitious, but it's a natural evolution
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals files automatic mixed securities shelf [Seeking Alpha]Seeking Alpha
- Vertex Pharmaceuticals price target raised to $520 from $460 at Truist [Yahoo! Finance]Yahoo! Finance
- AM Best Assigns Credit Ratings to Torreyana Insurance Company, Inc. [Yahoo! Finance]Yahoo! Finance
- Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast? [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 2/10/25 - Beat
VRTX
Sec Filings
- 2/14/25 - Form 4
- 2/14/25 - Form 4
- 2/14/25 - Form 4
- VRTX's page on the SEC website